WEDNESDAY, March 9, 2022 (HealthDay News) — Pfizer Inc. announced Tuesday that it has launched a Phase 2/3 clinical trial of its COVID antiviral pill known as Paxlovid in children ages 6-17. A news release from the company said the trial will assess the safety and efficacy of the drugContinue Reading
WEDNESDAY, March 9, 2022 (HealthDay News) — Kids who’ve suffered a concussion are at heightened risk of mental health issues in the aftermath, a large new study suggests. The researchers found that compared with their peers, children and teenagers with a past concussion were 39% more likely to be diagnosedContinue Reading
WEDNESDAY, March 9, 2022 (HealthDay News) — School mask mandates helped protect students and staff last fall as the Delta variant spread, a new government report shows. Ironically, the finding arrived just as many U.S. school districts have dropped masking rules. In the study released Tuesday by the U.S. CentersContinue Reading
TUESDAY, March 8, 2022 (HealthDay News) — There are serious mental harms and high financial costs associated with so-called conversion therapy for LGBTQ people, researchers report. Conversion therapy attempts to make lesbian, gay, bisexual, transgender and queer people “straight.” Its safety and effectiveness has been discredited in multiple prior studies.Continue Reading
THURSDAY, March 3, 2022 (HealthDay News) — Each year, RSV sends as many as 58,000 kids under age 5 to U.S. hospitals, but a vaccine in development may dramatically reduce the risk for severe illness. RSV, short for Respiratory Syncytial Virus, typically circulates in fall, winter and spring, causing congestion,Continue Reading
WEDNESDAY, March 2, 2022 (HealthDay News) — If you’re a parent using Similac, Alimentum or EleCare infant formulas, here’s updated facts on the ongoing product recall. As the U.S. Food and Drug Administration investigates, Abbott Nutrition has recalled certain powdered formulas made at its Sturgis, Mich., facility. The products haveContinue Reading
TUESDAY, March 1, 2022 (HealthDay News) — Fresh data shows that Pfizer’s COVID vaccine is far less powerful at preventing infection among children ages 5 to 11 than teens, a finding that could leave some parents of younger children worried. The vaccine — the only one authorized for that ageContinue Reading
THURSDAY, Feb. 24, 2022 (HealthDay News) — A drug developed for an autoimmune disease shows promise in treating a potentially life-threatening inflammatory condition in children who’ve had COVID-19, researchers say. The rare condition is called multisystem inflammatory syndrome in children (MIS-C). It typically develops weeks to months after a childContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — Early on in the pandemic doctors observed that some children and teens infected with COVID-19 went on to develop a relatively rare, but potentially life-threatening, complication known as multisystem inflammatory syndrome in children (MIS-C). But new research out of the U.S. Centers forContinue Reading
WEDNESDAY, Feb. 23, 2022 (HealthDay News) — If they quit early on, there’s a good chance that teenage drug abusers can still succeed in life, researchers say. The findings show the importance of stopping drug use by early adulthood in order to protect future health and well-being, according to JakeContinue Reading